Author:
Edelman Martin J.,Hodgson Lydia,Rosenblatt Paula Y.,Christenson Robert H.,Vokes Everett E.,Wang Xiaofei,Kratzke Robert
Subject
Pulmonary and Respiratory Medicine,Oncology
Reference19 articles.
1. Comparison of serum growth factors and tumor markers as prognostic factors for survival in non-small cell lung cancer;Nieder;Anticancer Res,2003
2. Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer;Ardizzoni;Cancer,2006
3. Comparison of cytokeratin 19 expression in tumor tissue and serum CYFRA 21-1 levels in non-small cell lung cancer;Kosacka;Pol Arch Med Wewn,2009
4. Serum CYFRA 21-1 in advanced stage non-small cell lung cancer: an early measure of response;Vollmer;Clin Cancer Res,2003
5. Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy–Cancer and Leukemia Group B Trial 30203;Edelman;J Clin Oncol,2008
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献